Real-world outcomes among patients with advanced/metastatic renal cell carcinoma (mRCC) treated with cabozantinib or other tyrosine kinase inhibitors (TKIs) after checkpoint inhibitor (CPI) therapy.Daniel Yick Chin Heng, Aly‐Khan A. Lalani, Mickael Löthgren et al.|Journal of Clinical Oncology|2023Cited by 0
Abstract P1-12-11: Individualized Breast Cancer Treatment Strategies: Real-World Insights from the ROSE StudyAlessandra Fabi, Elisabetta Munzone, Luisa Carbognin et al.|Clinical Cancer Research|2025Cited by 0